Market Leads & Opportunities
United Kingdom-Cheshire: NHS Framework Agreement for Glatiramer acetate injection – North of England – Framework Lead
The current contract for NHS Framework Agreement for Glatiramer acetate injection – North of England – Framework Lead is projected to end on 28-FEB-22 and may be available for retender. NHS Framework Agreement for the supply of Glatiramer Acetate injection to the North of England region.
Offer reference number: CM/PHR/18/5565
Period of Framework Agreement: 1.9.2018 – 29.2.2020 with an option to extend at the Authority’s discretion for up to 24 months.
The Framework is intended for use by the Department of Health and Social Care, Public Health England and the NHS in England. The framework may also be used by private sector contractors and agents working on behalf of the above.
More Market Leads
- Organised Crime Threat Assessment
12 Apr 21
Serious and organised crime is resilient and versatile and continues to evolve and adapt to reduce the risks to its own business, maximise profits, exploit new opportunities and evade law enforcement. - GLOBAL MAJORITY FUND
12 Apr 21
The Awarding Authority is giving grants from this Comic Relief Fund. - RETURN TO PLAY: COMMUNITY ASSET FUND
12 Apr 21
Capital grants of between £10,001 and £50,000 are available to help clubs and community groups adapt and open places and spaces, so that sport and physical activity can happen during the pandemic.
- In association with::
